BioMed X signs research collaboration with Sanofi on artificial intelligence for drug development

0

Content of the article

First joint research project between Sanofi and the BioMed X Institute, co-creation of a next-generation virtual patient engine for the clinical translation of drug candidates

Advertisement 2

Content of the article

HEIDELBERG, Germany, Oct. 24, 2022 (GLOBE NEWSWIRE) — BioMed X today announced the launch of its first joint research project with Sanofi. Within this framework, a new research group to be established at the BioMed X Institute in Heidelberg, Germany, will focus on the development of a versatile computing platform capable of accurately predicting the efficacy of first-in-class drug candidates. class in virtual patient populations. .

The research collaboration will tackle one of the biggest bottlenecks in the pharmaceutical industry today: a 90% failure rate of new drug candidates during clinical development. The goal is to transform the practice of medicine through the use of digital data and artificial intelligence. As such, this project will benefit from Sanofi’s in-depth datasets and expertise. As a proof of concept, the initial model will focus on chronic immune-mediated diseases such as atopic dermatitis (AD) and inflammatory bowel disease (IBD).

Advertisement 3

Content of the article

“Over the past two years, we have gained significant experience in the field of artificial intelligence through our strategic partnership with AION Labs in Israel. Our new collaboration with Sanofi allows us to further expand our data science and AI expertise in Heidelberg, where we have developed an ideal incubation environment for biomedical innovation at the interface between academia and industry. “, Explain Christian Tidona, Founder and Managing Director of the BioMed X Institute.

“Identifying quality clinical candidates for the treatment of patients with unmet needs is one of the most rewarding parts of the research and development process,” said Frank Nestle, Global Head of Research and Chief Scientific Officer of Sanofi. “This groundbreaking research collaboration will allow us to partner with scientists with unique computational skills and diverse capabilities that will help us achieve our goals of bringing life-saving treatments to patients with chronic inflammatory diseases. This collaboration will be key to advancing our core mission of transforming drug discovery and development through the application of AI-based modeling and simulation.

Advertisement 4

Content of the article

A diverse team of talented early-career scientists who take on this challenge will be jointly selected by the two companies through the successful and unique recruitment model designed by BioMed X, which includes a global call for applications followed by a boot camp at five-day innovation. The winning team will be hosted for up to five years by the BioMed X Institute, which is integrated into the life sciences campus of the University of Heidelberg, less than an hour from the Sanofi Research & Development site. in Frankfurt.

The new team will join the 11 research groups at the BioMed X Institute already working with complex humans ex-vivo models and data science in oncology, immunology and neuroscience.

Interested candidates who wish to lead this research team are invited to respond to this international call for applications and submit a project proposal via the BioMed X career space at https://bio.mx/career before 8 January 2023.

Advertisement 5

Content of the article

About BioMed X

BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany, with a worldwide network of partner sites. Together with our partners, we identify big challenges in biomedical research and provide creative solutions by combining global crowdsourcing with local incubation of the world’s best early-career research talent. Each of BioMed X’s highly diverse research teams has access to state-of-the-art research infrastructure and is continually guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile and more fun.

Contact information:

Flavia Bianca Cristian
Recruitment & Communication Manager
[email protected]

+49 6221 426 11 706

Related images

Image 1: BioMed X logo

BioMed X Logo

Image 2: Virtual patient

virtual patient

This content was posted through the press release distribution service on Newswire.com.

Attachment

Advertisement 1

comments

Postmedia is committed to maintaining a lively yet civil discussion forum and encourages all readers to share their views on our articles. Comments can take up to an hour to be moderated before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread you follow, or if a user follows you comments. See our Community Guidelines for more information and details on how to adjust your email settings.

Share.

Comments are closed.